Works matching IS 11732563 AND DT 2013 AND VI 33 AND IP 10

Results: 9

The Efficacy and Safety of Switching to Ziprasidone from Olanzapine in Patients with Bipolar I Disorder: An 8-Week, Multicenter, Open-Label Study.

Published in:

Clinical Drug Investigation, 2013, v. 33, n. 10, p. 743, doi. 10.1007/s40261-013-0120-y

By:

Lee, Hwang-Bin;
Yoon, Bo-Hyun;
Kwon, Young-Joon;
Woo, Young;
Lee, Jung-Goo;
Kim, Moon-Doo;
Bahk, Won-Myong

Publication type:

Article

Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant.

Published in:

Clinical Drug Investigation, 2013, v. 33, n. 10, p. 727, doi. 10.1007/s40261-013-0117-6

By:

Chen, Grace;
Lee, Ronald;
Højer, Astrid-Maria;
Buchbjerg, Jeppe;
Serenko, Michael;
Zhao, Zhen

Publication type:

Article

Efficacy and Safety of Mildronate for Acute Ischemic Stroke: A Randomized, Double-Blind, Active-Controlled Phase II Multicenter Trial.

Published in:

Clinical Drug Investigation, 2013, v. 33, n. 10, p. 755, doi. 10.1007/s40261-013-0121-x

By:

Zhu, Yi;
Zhang, Guangyun;
Zhao, Jun;
Li, Deshuai;
Yan, Xiaodong;
Liu, Juanfang;
Liu, Xuedong;
Zhao, Haibo;
Xia, Jielai;
Zhang, Xiao;
Li, Zhengyi;
Zhang, Baorong;
Guo, Zongcheng;
Feng, Lianyuan;
Zhang, Zhaodong;
Qu, Fang;
Zhao, Gang

Publication type:

Article

The Comparison of 24-Hour Urinary Sodium, Albumin, and Protein Excretion in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus Using Insulin Detemir or Insulin Glargine.

Published in:

Clinical Drug Investigation, 2013, v. 33, n. 10, p. 773, doi. 10.1007/s40261-013-0118-5

By:

Afsar, Baris

Publication type:

Article

Treatment Costs of Bladder Pain Syndrome/Interstitial Cystitis in Austria: A Pharmacoeconomic Approach Following Current Guidelines.

Published in:

Clinical Drug Investigation, 2013, v. 33, n. 10, p. 737, doi. 10.1007/s40261-013-0119-4

By:

Riedl, Claus;
Engelhardt, Paul;
Schwarz, Bernhard

Publication type:

Article

Safety and Tolerability of an Intra-seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-interventional Observational Study Investigating the Feasibility During Routine Administration.

Published in:

Clinical Drug Investigation, 2013, v. 33, n. 10, p. 719, doi. 10.1007/s40261-013-0115-8

By:

Schwab, Jan-Alexander;
Wolf, Hendrik;
Schnitker, Jörg;
Wüstenberg, Eike

Publication type:

Article

Saxagliptin Add-on Therapy to Insulin With or Without Metformin for Type 2 Diabetes Mellitus: 52-Week Safety and Efficacy.

Published in:

Clinical Drug Investigation, 2013, v. 33, n. 10, p. 707, doi. 10.1007/s40261-013-0107-8

By:

Barnett, Anthony;
Charbonnel, Bernard;
Li, Jia;
Donovan, Mark;
Fleming, Douglas;
Iqbal, Nayyar

Publication type:

Article

Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study.

Published in:

Clinical Drug Investigation, 2013, v. 33, n. 10, p. 761, doi. 10.1007/s40261-013-0126-5

By:

Mago, Rajnish;
Forero, Giovanna;
Greenberg, William;
Gommoll, Carl;
Chen, Changzheng

Publication type:

Article

Effective Achievement of Hemoglobin Stability with Once-Monthly C.E.R.A. in Peritoneal Dialysis Patients: A Prospective Study.

Published in:

Clinical Drug Investigation, 2013, v. 33, n. 10, p. 699, doi. 10.1007/s40261-013-0091-z

By:

Koch, Michael;
Treiber, Wolfgang;
Fliser, Danilo

Publication type:

Article